CompletedNot Applicable

An Explorative RVA of the Motor Development of Children With DCD <2y

Belgium, Canada49 participantsStarted 2020-09-14

Plain-language summary

This study compares motor development in three groups of infants (controls, DCD, DCD+ASD) before the age of 2 years using retrospective video analysis of infants in home video contexts.

Who can participate

Age range

6 Years – 12 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

CONTROLS: Inclusion Criteria: * Availability of video material of the child before the age of 2. * No indication of DCD (as measured by M-ABC-2 Pc\>16 and DCD-Q) * No indication of ASD (as measured by SRS-2 T-score ≤60 ) Exclusion Criteria: * Medical diagnosis possibly influencing motor development (DCD, ASD, ADHD, CP, ect) * Severe ilnesses in the early Developmental period (0-2y) which may have influenced the development (f.e. CVA, cancer, severe traumas,...) * Prolonged admission to the hospital (≥ 3 weeks) in the early Developmental period (0-2y) DCD GROUP: Inclusion criteria: * Availability of video material of the child before the age of 2. * Formal diagnosis of DCD provided by multidisciplinary team in Flanders * Indication of DCD (as measured by M-ABC-2 Pc≤16 and DCD-Q) Exclusion Criteria: * Other medical diagnosis possibly influencing motor development (ASD, ADHD, CP, ect) * Severe ilnesses in the early Developmental period (0-2y) which may have influenced the development (f.e. CVA, cancer, severe traumas,...) * Prolonged admission to the hospital (≥ 3 weeks) in the early Developmental period (0-2y) DCD+ASD GROUP: Inclusion criteria: * Availability of video material of the child before the age of 2. * Formal diagnosis of DCD and ASD provided by multidisciplinary team in Flanders * Indication of DCD (as measured by M-ABC-2 Pc≤16 and DCD-Q) * Indication of ASD (as measured by SRS-2 T-score \>60 ) Exclusion Criteria: * Other medical diagnosis possibly infl…

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Observable Movement Quality Scale

Timeframe: 0-2years

Trial details

NCT IDNCT04126395

SponsorUniversity Ghent

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2023-07-25

View on ClinicalTrials.gov More Developmental Coordination Disorder trials

Who can participate

Age range

6 Years – 12 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.